22 related articles for article (PubMed ID: 3756875)
1. Microspectrofluorometry of the protonation state of ellipticine, an antitumor alkaloid, in single cells.
Sureau F; Moreau F; Millot JM; Manfait M; Allard B; Aubard J; Schwaller MA
Biophys J; 1993 Nov; 65(5):1767-74. PubMed ID: 8298010
[TBL] [Abstract][Full Text] [Related]
2. Suramin is an inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells.
Bojanowski K; Lelievre S; Markovits J; Couprie J; Jacquemin-Sablon A; Larsen AK
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):3025-9. PubMed ID: 1313577
[TBL] [Abstract][Full Text] [Related]
3. Attempts to target antitumor drugs toward opioid receptor-rich mouse tumor cells with enkephalin-ellipticinium conjugates.
Rigaudy P; Charcosset JY; Garbay-Jaureguiberry C; Jacquemin-Sablon A; Roques BP
Cancer Res; 1989 Apr; 49(7):1836-42. PubMed ID: 2538235
[TBL] [Abstract][Full Text] [Related]
4. Effects of ellipticine on cell survival and cell cycle progression in cultured mammalian cells.
Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
Cancer Res; 1980 Jul; 40(7):2390-9. PubMed ID: 6155993
[TBL] [Abstract][Full Text] [Related]
5. Effects of the 6-alkyl substitution of ellipticine on the uptake by NIH-3T3 cells and on the cytotoxicity.
Deprés JP; Larue L; Paoletti J; Gouyette A
Anticancer Res; 1988; 8(1):191-6. PubMed ID: 3358635
[TBL] [Abstract][Full Text] [Related]
6. Monitoring uptake of ellipticine and its fluorescence lifetime in relation to the cell cycle phase by flow cytometry.
Sailer BL; Valdez JG; Steinkamp JA; Darzynkiewicz Z; Crissman HA
Exp Cell Res; 1997 Oct; 236(1):259-67. PubMed ID: 9344606
[TBL] [Abstract][Full Text] [Related]
7. Accessibility to bacterial nucleic acids of the intercalating drug aliphatic amino acid ellipticinium derivatives in Escherichia coli and Salmonella typhimurium.
Banoun H; Le Bret M; Auclair C
Biochemistry; 1985 Jan; 24(3):701-7. PubMed ID: 3888261
[TBL] [Abstract][Full Text] [Related]
8. [Sanguinarine and ellipticine cytotoxic alkaloids isolated from well-known antitumor plants. Intracellular targets of their action].
Faddeeva MD; Beliaeva TN
Tsitologiia; 1997; 39(2-3):181-208. PubMed ID: 9312909
[TBL] [Abstract][Full Text] [Related]
9. A novel chemical approach to drug delivery: lipidic amino acid conjugates.
Toth I
J Drug Target; 1994; 2(3):217-39. PubMed ID: 7812692
[TBL] [Abstract][Full Text] [Related]
10. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
Chari RV
Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
[TBL] [Abstract][Full Text] [Related]
11. Uptake, cytofluorescence, and cytotoxicity of oxazolopyridocarbazoles (amino acid-ellipticine conjugates) in murine sarcoma cells.
Larsen AK; Paoletti J; Belehradek J; Paoletti C
Cancer Res; 1986 Oct; 46(10):5236-40. PubMed ID: 3756875
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
